Neoadjuvant chemotherapy for advanced ovarian cancer: the tail of the scorpion for radical debulking surgery?

Affiliations

Free article

Editorial

Christina Fotopoulou. Int J Gynecol Cancer. 2020 Nov.

Free article

. 2020 Nov;30(11):1665-1666.

doi: 10.1136/ijgc-2020-002081. Epub 2020 Oct 12.

¹ Gynaecologic Oncology, Imperial College London Faculty of Medicine, London, UK chfotopoulou@gmail.com.

No abstract available

Keywords: ovarian cancer.

Conflict of interest statement

Competing interests: None declared.

Randomized trial of primary debulking surgery versus neoadjuvant chemotherapy for advanced epithelial ovarian cancer (SCORPION-NCT01461850).
Fagotti A, Ferrandina MG, Vizzielli G, Pasciuto T, Fanfani F, Gallotta V, Margariti PA, Chiantera V, Costantini B, Gueli Alletti S, Cosentino F, Scambia G. Fagotti A, et al. Int J Gynecol Cancer. 2020 Nov;30(11):1657-1664. doi: 10.1136/ijgc-2020-001640. Epub 2020 Oct 7. Int J Gynecol Cancer. 2020. PMID: 33028623 Clinical Trial.